Susceptibility of Schistosoma japonicum to praziquantel in China

Tropical Medicine and International Health

Volumn 6, Issue 9, 2001, Pages 707-714

  Liang, You Sheng ^a,e   Dai, Jian Rong ^a   Ning, An ^b   Yu, Dong Bao ^c   Xu, Xing Jian ^d   Zhu, Yin Chang ^a   Coles, Gerald C ^e  

^a JIANGSU INSTITUTE OF PARASITIC DISEASES   (China)

^b Jiangxi Inst of Parasitic Diseases   (China)

^c HUNAN INSTITUTE OF PARASITIC DISEASES   (China)

^d Hubei Institute of Schistosomiasis Control   (China)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Chemotherapy; China; Drug resistance; Praziquantel; S. mansoni; Schistosoma japonicum; Schistosomiasis

Indexed keywords

PRAZIQUANTEL;

DISEASE CONTROL; DRUG PRESCRIBING; PERFORMANCE ASSESSMENT; SCHISTOSOMIASIS;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHINA; DRUG SENSITIVITY; FECES ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS;

ADOLESCENT; ADULT; ANIMALS; ANTHELMINTICS; CHILD; CHILD, PRESCHOOL; CHINA; DRUG RESISTANCE; FEMALE; HUMANS; LIFE CYCLE STAGES; MALE; PRAZIQUANTEL; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS JAPONICA;

CHINA;

SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; TREMATODA;

EID: 0034851782     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2001.00772.x     Document Type: Article

References (29)

1. Praziquantel: Mechanisms of anti-schistosomal activity
2. Parasitic infection in China: Farewell to the God of Plagues
3. Antischistosomal drugs and clinical practice
4. Drug-resistant schistosomiasis: Resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific
5. Schistosoma mansoni: Maturation rate and drug susceptibility of different geographic isolates
6. Diminished praziquantel cure rates in a Senegal isolate of Schistosoma mansoni
7. Praziquantel: Mode of its antischistosomal action
8. Clinical use of praziquantel in China
9. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal
10. Therapeutic evaluation of two different dose regimens of praziquantel in a recent Schistosoma mansoni focus in northern Senegal
11. Application of praziquantel in control program
12. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerated high does of praziquantel
13. Use of praziquantel against schistosomiasis: A review of current status
14. Detection of praziquantel resistance in schistosomes
15. Experimental diagnosis, Chapter 8
16. Schistosomiasis control in the People's Republic of China
17. Schistosoma mansoni: Chemotherapy of infections of different ages
18. Effect of praziquantel on adult oriental schistosomes
19. Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni
20. Presentation and outcome of 1107 cases of schistosomiasis from Africa diagnosed in a non-endemic country
21. Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo
22. Susceptibility of Schistosoma japonicum of different development stages to praziquantel
23. Studies on comparisons of modified Kato's, egg hatching and sediment counting methods for detecting ova of Schistosoma joponicum
24. Effect of praziquantel in vitro on different development stages of Schistosoma japonicum
25. Studies on diagnosis of schistosomiasis using faecal egg concentration method with a nylon tissue bag
26. Epidemiological features and control strategies of schistosomiasis japonica in China
27. A brief introduction to nation-wide sampling survey on schistosomiasis